Baumer

Baumer EBIT per Share

The EBIT per Share of Baumer (BALM4.SA) as of Nov 9, 2026 is 3.68 BRL. In the previous year, EBIT per Share was 2.25 BRL — a change of 63.64% (higher).

EBIT per Share

3.68BRL

YoY

63.64%

Last updated:

EBIT per Share of Baumer is 2024 3.68 BRL. EBIT per Share of Baumer was 2023 2.25 BRL. It decreases by 63.64% higher compared to the previous year.

The Baumer EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2017
0.34 BRL
Jan 1, 2018
0.55 BRL
Jan 1, 2019
0.94 BRL
Jan 1, 2020
1.74 BRL
Jan 1, 2021
1.25 BRL
Jan 1, 2022
1.83 BRL
Jan 1, 2023
2.25 BRL
Jan 1, 2024
3.68 BRL
The Baumer EBIT per Share history
YEAREBIT per ShareYoY
3.68BRL+63.64%
2.25BRL+23.09%
1.83BRL+46.15%
1.25BRL-28.27%
1.74BRL+86.30%
0.94BRL+69.93%
0.55BRL+62.46%
0.34BRL-64.14%
0.95BRL-35.24%
1.46BRL-17.00%
1.76BRL-9.77%
1.95BRL+46.92%
1.33BRL+32.65%
1.00BRL+19.51%
0.84BRL+30.16%
0.64BRL+28.57%
0.50BRL+22.97%
0.41BRL-47.89%
0.78BRL+16.39%
0.67BRL—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

EBIT per Share of Baumer is 3.68 BRL in 2024.

EBIT per Share of Baumer changed from 2.25 BRL to 3.68 BRL, representing a 63.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Baumer since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Baumer

All Key Metrics — Baumer